Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression

<div>Enrollment scheme and outcomes of selected patients with progressive disease among patients with hepatocellular carcinoma who failed to respond to initial sorafenib treatment.</div>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression 

Figure 1 | Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression 